CA Stock MarketDetailed Quotes

TSLA Tesla CDR (CAD Hedged)

Watchlist
  • 25.630
  • +0.100+0.39%
15min DelayMarket Closed Apr 28 16:00 ET
1.24TMarket Cap152.56P/E (TTM)

Tesla CDR (CAD Hedged) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
-9.23%19.34B
0.95%97.69B
2.15%25.71B
7.85%25.18B
2.30%25.5B
-8.69%21.3B
18.80%96.77B
3.49%25.17B
8.84%23.35B
47.20%24.93B
Operating revenue
-9.23%19.34B
0.95%97.69B
2.15%25.71B
7.85%25.18B
2.30%25.5B
-8.69%21.3B
18.80%96.77B
3.49%25.17B
8.84%23.35B
47.20%24.93B
Cost of revenue
-8.08%16.18B
1.42%80.24B
3.85%21.53B
5.28%20.19B
2.59%20.92B
-6.45%17.61B
30.53%79.11B
11.80%20.73B
19.29%19.17B
60.58%20.39B
Gross profit
-14.69%3.15B
-1.19%17.45B
-5.84%4.18B
19.60%5B
0.99%4.58B
-18.07%3.7B
-15.31%17.66B
-23.18%4.44B
-22.37%4.18B
7.06%4.53B
Operating expense
5.35%2.66B
10.50%9.69B
9.06%2.59B
-7.83%2.23B
10.17%2.35B
36.71%2.53B
24.90%8.77B
28.88%2.37B
42.50%2.41B
31.08%2.13B
Selling and administrative expenses
-8.95%1.25B
7.29%5.15B
2.58%1.31B
-5.35%1.19B
7.22%1.28B
27.70%1.37B
21.64%4.8B
24.03%1.28B
30.39%1.25B
23.93%1.19B
Research and development costs
22.42%1.41B
14.39%4.54B
16.64%1.28B
-10.51%1.04B
13.89%1.07B
49.29%1.15B
29.07%3.97B
35.06%1.09B
58.39%1.16B
41.38%943M
Operating profit
-57.90%493M
-12.72%7.76B
-22.97%1.59B
57.14%2.77B
-7.17%2.23B
-56.04%1.17B
-35.72%8.89B
-47.55%2.06B
-52.17%1.76B
-7.94%2.4B
Net non-operating interest income (expenses)
12.77%309M
33.96%1.22B
27.21%346M
38.11%337M
24.76%262M
48.91%274M
758.49%910M
119.35%272M
639.39%244M
1,266.67%210M
Non-operating interest income
14.29%400M
47.19%1.57B
32.73%442M
52.13%429M
46.22%348M
64.32%350M
258.92%1.07B
112.10%333M
227.91%282M
815.38%238M
Non-operating interest expense
19.74%91M
124.36%350M
57.38%96M
142.11%92M
207.14%86M
162.07%76M
-18.32%156M
84.85%61M
-28.30%38M
-36.36%28M
Other net income (expenses)
-148.08%-213M
-93.60%11M
672.41%830M
-978.38%-325M
-283.54%-602M
1,022.92%443M
178.54%172M
-90.79%-145M
143.53%37M
387.72%328M
Special income (charges)
---94M
---684M
---7M
---55M
---622M
--0
--0
--0
--0
--0
-Less:Restructuring and mergern&acquisition
--94M
--684M
--7M
--55M
--622M
--0
--0
--0
--0
--0
Other non-operating income (expenses)
-126.86%-119M
304.07%695M
677.24%837M
-829.73%-270M
-93.90%20M
1,022.92%443M
500.00%172M
-245.24%-145M
143.53%37M
1,071.43%328M
Income before tax
-68.80%589M
-9.86%8.99B
26.24%2.77B
36.14%2.78B
-35.75%1.89B
-32.57%1.89B
-27.31%9.97B
-44.99%2.19B
-43.76%2.05B
18.71%2.94B
Income tax
-65.01%169M
136.73%1.84B
107.55%434M
259.88%601M
21.67%393M
85.06%483M
-541.78%-5B
-2,184.06%-5.75B
-45.25%167M
57.56%323M
Earnings from equity interest net of tax
Net income
-70.11%420M
-52.23%7.15B
-70.64%2.33B
16.24%2.18B
-42.85%1.49B
-44.66%1.41B
18.96%14.97B
114.27%7.94B
-43.62%1.88B
15.20%2.61B
Net income continuous operations
-70.11%420M
-52.23%7.15B
-70.64%2.33B
16.24%2.18B
-42.85%1.49B
-44.66%1.41B
18.96%14.97B
114.27%7.94B
-43.62%1.88B
15.20%2.61B
Noncontrolling interests
-26.67%11M
192.00%23M
-284.62%-24M
-36.00%16M
117.98%16M
-42.31%15M
-725.00%-25M
285.71%13M
-35.90%25M
-990.00%-89M
Net income attributable to the company
-70.58%409M
-52.46%7.13B
-70.29%2.36B
16.95%2.17B
-45.32%1.48B
-44.69%1.39B
19.20%15B
113.52%7.93B
-43.71%1.85B
19.65%2.7B
Preferred stock dividends
Other under preferred stock dividend
0
0
-740.00%-42M
2M
Net income attributable to common stockholders
-71.44%409M
-52.46%7.13B
-70.81%2.31B
17.07%2.17B
-45.32%1.48B
-43.13%1.43B
19.20%15B
112.98%7.93B
-43.77%1.85B
19.81%2.7B
Diluted earnings per share
-71.11%0.0087
-52.85%0.1487
-71.08%0.048
17.24%0.0453
-45.88%0.0307
-43.75%0.03
17.66%0.3154
111.02%0.166
-44.76%0.0387
16.44%0.0567
Basic earnings per share
-70.73%0.008
-52.56%0.136
-70.93%0.044
16.98%0.0413
-46.15%0.028
-43.84%0.0273
18.78%0.2867
112.15%0.1514
-44.21%0.0353
20.00%0.052
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue -9.23%19.34B0.95%97.69B2.15%25.71B7.85%25.18B2.30%25.5B-8.69%21.3B18.80%96.77B3.49%25.17B8.84%23.35B47.20%24.93B
Operating revenue -9.23%19.34B0.95%97.69B2.15%25.71B7.85%25.18B2.30%25.5B-8.69%21.3B18.80%96.77B3.49%25.17B8.84%23.35B47.20%24.93B
Cost of revenue -8.08%16.18B1.42%80.24B3.85%21.53B5.28%20.19B2.59%20.92B-6.45%17.61B30.53%79.11B11.80%20.73B19.29%19.17B60.58%20.39B
Gross profit -14.69%3.15B-1.19%17.45B-5.84%4.18B19.60%5B0.99%4.58B-18.07%3.7B-15.31%17.66B-23.18%4.44B-22.37%4.18B7.06%4.53B
Operating expense 5.35%2.66B10.50%9.69B9.06%2.59B-7.83%2.23B10.17%2.35B36.71%2.53B24.90%8.77B28.88%2.37B42.50%2.41B31.08%2.13B
Selling and administrative expenses -8.95%1.25B7.29%5.15B2.58%1.31B-5.35%1.19B7.22%1.28B27.70%1.37B21.64%4.8B24.03%1.28B30.39%1.25B23.93%1.19B
Research and development costs 22.42%1.41B14.39%4.54B16.64%1.28B-10.51%1.04B13.89%1.07B49.29%1.15B29.07%3.97B35.06%1.09B58.39%1.16B41.38%943M
Operating profit -57.90%493M-12.72%7.76B-22.97%1.59B57.14%2.77B-7.17%2.23B-56.04%1.17B-35.72%8.89B-47.55%2.06B-52.17%1.76B-7.94%2.4B
Net non-operating interest income (expenses) 12.77%309M33.96%1.22B27.21%346M38.11%337M24.76%262M48.91%274M758.49%910M119.35%272M639.39%244M1,266.67%210M
Non-operating interest income 14.29%400M47.19%1.57B32.73%442M52.13%429M46.22%348M64.32%350M258.92%1.07B112.10%333M227.91%282M815.38%238M
Non-operating interest expense 19.74%91M124.36%350M57.38%96M142.11%92M207.14%86M162.07%76M-18.32%156M84.85%61M-28.30%38M-36.36%28M
Other net income (expenses) -148.08%-213M-93.60%11M672.41%830M-978.38%-325M-283.54%-602M1,022.92%443M178.54%172M-90.79%-145M143.53%37M387.72%328M
Special income (charges) ---94M---684M---7M---55M---622M--0--0--0--0--0
-Less:Restructuring and mergern&acquisition --94M--684M--7M--55M--622M--0--0--0--0--0
Other non-operating income (expenses) -126.86%-119M304.07%695M677.24%837M-829.73%-270M-93.90%20M1,022.92%443M500.00%172M-245.24%-145M143.53%37M1,071.43%328M
Income before tax -68.80%589M-9.86%8.99B26.24%2.77B36.14%2.78B-35.75%1.89B-32.57%1.89B-27.31%9.97B-44.99%2.19B-43.76%2.05B18.71%2.94B
Income tax -65.01%169M136.73%1.84B107.55%434M259.88%601M21.67%393M85.06%483M-541.78%-5B-2,184.06%-5.75B-45.25%167M57.56%323M
Earnings from equity interest net of tax
Net income -70.11%420M-52.23%7.15B-70.64%2.33B16.24%2.18B-42.85%1.49B-44.66%1.41B18.96%14.97B114.27%7.94B-43.62%1.88B15.20%2.61B
Net income continuous operations -70.11%420M-52.23%7.15B-70.64%2.33B16.24%2.18B-42.85%1.49B-44.66%1.41B18.96%14.97B114.27%7.94B-43.62%1.88B15.20%2.61B
Noncontrolling interests -26.67%11M192.00%23M-284.62%-24M-36.00%16M117.98%16M-42.31%15M-725.00%-25M285.71%13M-35.90%25M-990.00%-89M
Net income attributable to the company -70.58%409M-52.46%7.13B-70.29%2.36B16.95%2.17B-45.32%1.48B-44.69%1.39B19.20%15B113.52%7.93B-43.71%1.85B19.65%2.7B
Preferred stock dividends
Other under preferred stock dividend 00-740.00%-42M2M
Net income attributable to common stockholders -71.44%409M-52.46%7.13B-70.81%2.31B17.07%2.17B-45.32%1.48B-43.13%1.43B19.20%15B112.98%7.93B-43.77%1.85B19.81%2.7B
Diluted earnings per share -71.11%0.0087-52.85%0.1487-71.08%0.04817.24%0.0453-45.88%0.0307-43.75%0.0317.66%0.3154111.02%0.166-44.76%0.038716.44%0.0567
Basic earnings per share -70.73%0.008-52.56%0.136-70.93%0.04416.98%0.0413-46.15%0.028-43.84%0.027318.78%0.2867112.15%0.1514-44.21%0.035320.00%0.052
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.